Literature DB >> 33474686

Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.

Eric G Benz1,2, Erum A Hartung3,4.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are characterized by bilateral cystic kidney disease leading to progressive kidney function decline. These diseases also have distinct liver manifestations. The range of clinical presentation and severity of both ADPKD and ARPKD is much wider than was once recognized. Pediatric and adult nephrologists are likely to care for individuals with both diseases in their lifetimes. This article will review genetic, clinical, and imaging predictors of kidney and liver disease progression in ADPKD and ARPKD and will briefly summarize pharmacologic therapies to prevent progression.
© 2021. IPNA.

Entities:  

Keywords:  Children; Outcomes; Polycystic kidney disease; Progression; Stage 5 chronic kidney disease

Mesh:

Year:  2021        PMID: 33474686      PMCID: PMC8292447          DOI: 10.1007/s00467-020-04869-w

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  145 in total

1.  The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Annick Rousseau; Maryvonne Hourmant; Eric Renaudineau; Christophe Charasse; Marie-Pascale Morin; Marie-Christine Moal; Jacques Dantal; Bassem Wehbe; Régine Perrichot; Thierry Frouget; Cécile Vigneau; Jérôme Potier; Philippe Jousset; Marie-Paule Guillodo; Pascale Siohan; Nazim Terki; Théophile Sawadogo; Didier Legrand; Victorio Menoyo-Calonge; Seddik Benarbia; Dominique Besnier; Hélène Longuet; Claude Férec; Yannick Le Meur
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

2.  Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.

Authors:  Meral Gunay-Aygun; Esperanza Font-Montgomery; Linda Lukose; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Kailash T Daryanani; Baris Turkbey; Roxanne Fischer; Isa Bernardini; Murat Sincan; Xiongce Zhao; Netanya G Sandler; Annelys Roque; Daniel C Douek; Jennifer Graf; Marjan Huizing; Joy C Bryant; Parvathi Mohan; William A Gahl; Theo Heller
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

3.  Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model.

Authors:  Xiaofang Wang; Megan M Constans; Fouad T Chebib; Vicente E Torres; Lorenzo Pellegrini
Journal:  Am J Nephrol       Date:  2019-05-22       Impact factor: 3.754

4.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

5.  Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).

Authors:  W Charles O'Neill; Michelle L Robbin; Kyongtae T Bae; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Vicente E Torres; Bernard F King; Louis H Wetzel; Paul A Thompson; J Philip Miller
Journal:  Am J Kidney Dis       Date:  2005-12       Impact factor: 8.860

6.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

7.  Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.

Authors:  Lisa M Guay-Woodford; John J Bissler; Michael C Braun; Detlef Bockenhauer; Melissa A Cadnapaphornchai; Katherine M Dell; Larissa Kerecuk; Max C Liebau; Maria H Alonso-Peclet; Benjamin Shneider; Sukru Emre; Theo Heller; Binita M Kamath; Karen F Murray; Kenneth Moise; Eric E Eichenwald; Jacquelyn Evans; Roberta L Keller; Louise Wilkins-Haug; Carsten Bergmann; Meral Gunay-Aygun; Stephen R Hooper; Kristina K Hardy; Erum A Hartung; Randi Streisand; Ronald Perrone; Marva Moxey-Mims
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

8.  ADPedKD: A Global Online Platform on the Management of Children With ADPKD.

Authors:  Stéphanie De Rechter; Detlef Bockenhauer; Lisa M Guay-Woodford; Isaac Liu; Andrew J Mallett; Neveen A Soliman; Lucimary C Sylvestre; Franz Schaefer; Max C Liebau; Djalila Mekahli
Journal:  Kidney Int Rep       Date:  2019-05-29

9.  Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.

Authors:  Ragada El-Damanawi; Michael Lee; Tess Harris; Laura B Mader; Simon Bond; Holly Pavey; Richard N Sandford; Ian B Wilkinson; Alison Burrows; Przemyslaw Woznowski; Yoav Ben-Shlomo; Fiona E Karet Frankl; Thomas F Hiemstra
Journal:  BMJ Open       Date:  2018-05-09       Impact factor: 2.692

10.  Transient Elastography for Detection of Liver Fibrosis in Children With Autosomal Recessive Polycystic Kidney Disease.

Authors:  Dorota Wicher; Irena Jankowska; Patryk Lipiński; Paulina Szymańska-Rożek; Jakub Kmiotek; Wojciech Jańczyk; Jacek Rubik; Krystyna Chrzanowska; Piotr Socha
Journal:  Front Pediatr       Date:  2019-01-11       Impact factor: 3.418

View more
  1 in total

1.  A 7-year-old girl with renal medullary hyperechogenicity and hypertension: Answers.

Authors:  İlknur Girişgen; Selcuk Yüksel; Furkan Ufuk; Taner Durak; Tülay Becerir
Journal:  Pediatr Nephrol       Date:  2021-10-11       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.